• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨肉瘤中的自发性坏死。

Spontaneous necrosis in osteosarcomas.

作者信息

von Hochstetter A R

机构信息

Department of Pathology, University Hospital, Zurich, Switzerland.

出版信息

Virchows Arch A Pathol Anat Histopathol. 1990;417(1):5-8. doi: 10.1007/BF01600102.

DOI:10.1007/BF01600102
PMID:2113741
Abstract

In the treatment of osteosarcoma pre-operative chemotherapy has assumed considerable importance in helping improve survival, and enabling limb-sparing procedures. The quantitative assessment of tumour necrosis in the resected specimen by morphological means has become a significant step in judging therapeutic response and in helping determine post-operative management. Different systems of grading tumour regression have been proposed. Little is known, however, about the morphology or degree of spontaneous necrosis in osteosarcomas, in particular to what extent necrosis can be considered to be due to cytotoxic treatment. For this purpose, 13 osteosarcomas, taken from patients treated by surgery alone, were examined by the same method we routinely employ in assessing chemotherapeutic response. The results demonstrate that the extent of spontaneous necrosis does not approach that achieved in response to chemotherapy. Sub-total necrosis may be due to spontaneous regression, inadequate therapeutic response, or to a combination of both. Hence, only two categories of response, good and poor, appear relevant and these terms should be used in preference to good, intermediate and poor.

摘要

在骨肉瘤的治疗中,术前化疗对于提高生存率以及实施保肢手术起着相当重要的作用。通过形态学方法对切除标本中的肿瘤坏死进行定量评估,已成为判断治疗反应及确定术后管理的重要步骤。人们提出了不同的肿瘤消退分级系统。然而,对于骨肉瘤的自发坏死形态或程度,尤其是坏死在多大程度上可被认为是由细胞毒性治疗所致,了解甚少。为此,我们采用在评估化疗反应时常规使用的相同方法,对13例仅接受手术治疗的患者的骨肉瘤进行了检查。结果表明,自发坏死的程度不及化疗所达到的程度。次全坏死可能是由于自发消退、治疗反应不足或两者兼而有之。因此,似乎只有良好和差这两类反应是相关的,并且应优先使用这两个术语,而不是良好、中等和差。

相似文献

1
Spontaneous necrosis in osteosarcomas.骨肉瘤中的自发性坏死。
Virchows Arch A Pathol Anat Histopathol. 1990;417(1):5-8. doi: 10.1007/BF01600102.
2
Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.化疗期间采用扩散加权磁共振成像评估肿瘤坏死:骨肉瘤的初步结果
Pediatr Radiol. 2006 Dec;36(12):1306-11. doi: 10.1007/s00247-006-0324-x. Epub 2006 Oct 10.
3
Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.术前联合顺铂动脉内注射和阿霉素持续静脉滴注治疗高级别骨肉瘤。
Oncol Rep. 1999 May-Jun;6(3):631-7. doi: 10.3892/or.6.3.631.
4
Spontaneous necrosis in osteosarcoma.骨肉瘤中的自发性坏死。
Clin Orthop Relat Res. 1991 Feb(263):233-7.
5
Spontaneous necrosis in osteosarcomas.骨肉瘤中的自发性坏死。
Chir Organi Mov. 1990;75(1 Suppl):32-5.
6
Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.肢体非转移性骨肉瘤的新辅助化疗及延迟手术。164例患者术前接受大剂量甲氨蝶呤治疗,随后使用顺铂和阿霉素。
Cancer. 1993 Dec 1;72(11):3227-38. doi: 10.1002/1097-0142(19931201)72:11<3227::aid-cncr2820721116>3.0.co;2-c.
7
Prognostic significance of spontaneous tumour necrosis in osteosarcoma.骨肉瘤中自发肿瘤坏死的预后意义
Virchows Arch A Pathol Anat Histopathol. 1993;423(3):195-9. doi: 10.1007/BF01614770.
8
The value of computed tomographic measurements in osteosarcoma as a predictor of response to adjuvant chemotherapy.
Clin Radiol. 1994 Jan;49(1):19-23. doi: 10.1016/s0009-9260(05)82908-3.
9
[Comparison of x-ray and histological findings in osteosarcomas following preoperative chemotherapy].骨肉瘤术前化疗后X线与组织学检查结果的比较
Rofo. 1985 Jul;143(1):74-82. doi: 10.1055/s-2008-1052763.
10
Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution.在单一机构接受新辅助化疗的881例四肢非转移性骨肉瘤患者中,化疗诱导坏死的分级作为局部和全身控制的预测指标。
Eur J Cancer. 2005 Sep;41(14):2079-85. doi: 10.1016/j.ejca.2005.03.036.

引用本文的文献

1
Prognostic significance of spontaneous tumour necrosis in osteosarcoma.骨肉瘤中自发肿瘤坏死的预后意义
Virchows Arch A Pathol Anat Histopathol. 1993;423(3):195-9. doi: 10.1007/BF01614770.

本文引用的文献

1
The effect of chemotherapy on human bone sarcomas: a clinical and experimental study.化疗对人骨肉瘤的影响:一项临床与实验研究。
Recent Results Cancer Res. 1984;94:65-75. doi: 10.1007/978-3-642-82295-7_8.
2
[Determination of the degree of morphological regression following chemotherapy in malignant bone tumors].[恶性骨肿瘤化疗后形态学消退程度的测定]
Pathologe. 1983 May;4(3):135-41.
3
Osteogenic sarcoma.骨肉瘤
Clin Orthop Relat Res. 1986 Mar(204):93-110.
4
Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement.原发性骨肉瘤:20例患者经化疗、整块切除及人工骨置换治疗后的病理情况
Arch Pathol Lab Med. 1977 Jan;101(1):14-8.
5
Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.原发性骨肉瘤:术前化疗及延迟手术的理论依据
Cancer. 1979 Jun;43(6):2163-77. doi: 10.1002/1097-0142(197906)43:6<2163::aid-cncr2820430602>3.0.co;2-s.